BIOMÉRIEUX |
Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 95,8 EUR | -0,26% |
|
+2,13% | -4,82% |
| 30/05 | Veranderingen in de Europese portefeuille |  |
| 23/05 | BioMérieux en Pfizer gaan samenwerken aan een initiatief tegen antimicrobiële resistentie in Malawi | MT |
Vakgebied
- klinische toepassingen (84,4%): op industrieel gebied, de microbiologische controle van monsters van eindproducten of producten tijdens hun vervaardiging of van de omgeving, voornamelijk in de voedingsmiddelen-, farmaceutische en cosmeticasector;
- industriële toepassingen (15,6%).
De diagnosesystemen van het concern bestaan uit drie elementen en de bijbehorende diensten: reagens, instrumenten (of platformen of automaten), software en diensten.
De geografische verdeling van de omzet is de volgende: Europa-Midden-Oosten-Afrika (32.4%), Noord-Amerika (44.1%), Azië-Stille Oceaan (17,3%) en Latijns-Amerika (6,2%).
Aantal werknemers: 13 696
Verkoop per activiteit
| EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
|---|---|---|---|---|---|
Clinical Applications
84,3
%
| 3 040 | 84,7 % | 3 099 | 84,3 % | +1,95% |
Industrial Applications
15,7
%
| 549 | 15,3 % | 575 | 15,7 % | +4,79% |
Verkoop per regio
| EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
|---|---|---|---|---|---|
Americas
50,2
%
| 1 841 | 51,3 % | 1 846 | 50,2 % | +0,26% |
EMEA
26,3
%
| 901 | 25,1 % | 965 | 26,3 % | +7,05% |
Asia Pacific
17,4
%
| 624 | 17,4 % | 638 | 17,4 % | +2,15% |
France
6,1
%
| 220 | 6,1 % | 226 | 6,1 % | +2,64% |
Corporate
0,0
%
| 3 | 0,1 % | 1 | 0,0 % | -65,38% |
Managers
| Managers | Titel | Leeftijd | Van |
|---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 52 | 01-11-16 |
| Chairman | 50 | 16-04-04 | |
| Director of Finance/CFO | 47 | 01-03-18 | |
Jennifer Zinn
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-23 |
| Director/Board Member | 74 | 15-09-06 | |
Valérie Leyldé
IRO | Public Communications Contact | - | - |
Yasha Mitrotti
PRN | Corporate Officer/Principal | - | - |
Sylvain Morgeau
PRN | Corporate Officer/Principal | 44 | 01-01-11 |
| Corporate Officer/Principal | 58 | - |
Besturend
| Besturend | Titel | Leeftijd | Van |
|---|---|---|---|
| Director/Board Member | 74 | 15-09-06 | |
| Director/Board Member | 63 | 01-01-05 | |
| Chairman | 50 | 16-04-04 | |
| Director/Board Member | 59 | 30-05-12 | |
| Director/Board Member | 59 | 30-05-12 | |
Fanny Letier
BRD | Director/Board Member | 45 | 30-06-17 |
| Director/Board Member | 68 | 28-08-17 | |
Sylvain Orenga
BRD | Director/Board Member | - | 24-05-22 |
Aandelenklasse
| Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
|---|---|---|---|---|---|
| Aandeel A | 1 | 118 361 220 | 42 884 007 ( 36,23 %) | 206 987 ( 0,1749 %) | 36,23 % |
Participaties
| Naam | Aandelen | % | Totale waarde |
|---|---|---|---|
| 59 062 832 | 6.87% | 72 735 287 $ | |
BIOMÉRIEUX 0.17% | 201 318 | 0.17% | 21 525 927 $ |
Bedrijfsgegevens
Bedrijven van de groep
| Naam | Categorie en sector |
|---|---|
bioMérieux Asia Pacific Pte Ltd.
| |
Biofire Diagnostics, Inc.
 Biofire Diagnostics, Inc. Electronic Production EquipmentElectronic Technology Biofire Diagnostics, Inc. manufactures, markets and sales of the film array system. Its FilmArray is an FDA-cleared multiplex PCR system that integrates sample preparation, amplification, detection and analysis. The firm has three FDA cleared panels the respiratory Panel, the blood culture identification panel, and the Gastrointestinal Panel. The company was founded by Randy Rasmussen, Carl Wittwer and Kirk Ririe in 1990 and is headquartered in Salt Lake City, UT. |
Electronic Production Equipment
|
Applied Maths NV
 Applied Maths NV Packaged SoftwareTechnology Services Applied Maths NV develops software for the biosciences. It offers desktop software such as BioNumerics, GelCompar II, GeneMaths XT, and Kodon. It also offers server software such as BioNumerics server. The firm also offers services such as training workshops, on-site training, data analysis, and scripts development. The company was founded by Paul Vauterin and Luc Vauterin in 1992 and is headquartered in Sint-Martens-Latem, Belgium. |
Packaged Software
|
BioMerieux Benelux NV
| |
bioMérieux CZ sro
 bioMérieux CZ sro Medical SpecialtiesHealth Technology Part of Compagnie Merieux Alliance SAS, bioMérieux CZ sro is a company based in Prague, Czechia. The Czech company specializes in in vitro diagnostics and has been a leader in the field since 1963. The company offers a fully automated enumeration system called Tempo® for testing quality indicators in food products and environmental samples. The company also provides solutions for microbial quality control in the pharmaceutical industry and a complete line of diagnostic solutions for routine testing and rapid results to ensure patient safety. |
Medical Specialties
|
bioMérieux China Ltd. (HongKong)
 bioMérieux China Ltd. (HongKong) Medical DistributorsDistribution Services Part of Compagnie Merieux Alliance SAS, bioMérieux China Ltd. (HongKong) is a company located in Hong Kong that wholesales and distributes surgical and medical instruments. |
Medical Distributors
|
bioMérieux, Inc.
 bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. |
Medical Specialties
|
bioMérieux Sweden AB
| |
bioMérieux Italia SpA
 bioMérieux Italia SpA Medical SpecialtiesHealth Technology bioMérieux Italia SpA engages in research and development activities in the clinical diagnostics and industrial microbiology sectors. The firm focuses on treatments in the field of infectious diseases, cardiovascular emergencies, and targeted therapies for cancer. Its products and services also aim to prevent the risks of contamination in agri-food, pharmaceutical, and cosmetic products. The company was founded in 1985 and is headquartered in Bagno a Ripoli, Italy. |
Medical Specialties
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| -4,82% | 12,35 mld. | |
| -3,76% | 8,17 mld. | |
| +7,84% | 5,77 mld. | |
| +31,48% | 5,65 mld. | |
| -10,28% | 4,1 mld. | |
| +10,72% | 2,67 mld. | |
| -6,99% | 2,31 mld. | |
| +16,56% | 2,02 mld. | |
| -7,29% | 1,81 mld. | |
| -2,25% | 1,51 mld. |
